FOXA1 and breast carcinoma: The last known subtype, luminal androgen receptor (LAR), is found to overlap with the molecular apocrine group (“molecular apocrine breast cancer”/MABC) and is enriched in genes regulating hormone signaling, in particular androgen signaling and synthesis (AR, FOXA1, KRT18, XBP1) [70].